PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

ClinicalTrials.gov ID: NCT06665100

Public ClinicalTrials.gov record NCT06665100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of PUL-042 Inhalation Solution in Reducing Lower Respiratory Tract Complications in Patients With Hematologic Malignancies and Recipients of Hematopoietic Stem Cell Transplantation (HSCT) With Documented Viral Infections With PIV, hMPV or RSV

Study identification

NCT ID: NCT06665100
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Pulmotect, Inc.; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Interventions

PUL-042 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 26, 2025
Primary completion: Mar 31, 2027
Completion: Apr 30, 2027
Last update posted: Apr 23, 2026

2025 – 2027

United States locations

U.S. sites: 11
U.S. states: 11
U.S. cities: 11

Facility	City	State	ZIP	Site status
City of Hope National Medical Center	Duarte	California	91010	Recruiting
Northside Hospital	Atlanta	Georgia	30342	Recruiting
Johns Hopkins Hospital	Baltimore	Maryland	21205	Recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Recruiting
Barbara Ann Karmanos Cancer Institute	Detroit	Michigan	48201	Recruiting
University of Minnesota	Minneapolis	Minnesota	55455	Recruiting
John Theurer Cancer Center	Hackensack	New Jersey	07601	Recruiting
Lineberger Cancer	Chapel Hill	North Carolina	27514	Recruiting
OU Health Physicians - Infectious Disease Clinic	Oklahoma City	Oklahoma	73104	Recruiting
University of Texas MD Anderson MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
Fred Hutchinson Cancer Center	Seattle	Washington	98109	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06665100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 23, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06665100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →